Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
18
Number of overlapping holdings
23.7%
% of CNCR's 76 holdings also in IDNA
38.3%
% of IDNA's 51 holdings also in CNCR
Overlap by Weight
Sector Drift (CNCR minus IDNA)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
Company | Weight in CNCR |
Weight in IDNA |
Overlap | |
---|---|---|---|---|
IOVANCE BIOTHERAPEUTICS INC | 2.6% | 3.7% | 2.6% | |
REVOLUTION MEDICINES, INC. | 2.3% | 4.5% | 2.3% | |
ARCELLX, INC. | 2.0% | 3.0% | 2.0% | |
SPRINGWORKS THERAPEUTICS, INC. | 1.8% | 3.0% | 1.8% | |
GERON CORP | 1.4% | 1.9% | 1.4% |
Position Highlights (Non-Overlapping Exposures)
CNCR Overweight Relative to IDNA
JANUX THERAPEUTICS, INC. | 3.7% | |
MERSANA THERAPEUTICS, INC. | 3.1% | |
Y-MABS THERAPEUTICS, INC. | 3.0% | |
FATE THERAPEUTICS INC | 2.8% | |
IMMUNITYBIO INC | 2.1% | |
MORPHOSYS AG SPONSORED ADR | 2.1% | |
AUTOLUS THERAPEUTICS PLC SPONSORED A | 2.0% | |
KURA ONCOLOGY, INC. | 2.0% | |
KYMERA THERAPEUTICS, INC. | 2.0% | |
MACROGENICS INC | 1.8% |
CNCR Underweight Relative to IDNA
SAREPTA THERAPEUTICS INC | -5.4% | |
MODERNA, INC. | -4.7% | |
INCYTE CORP | -3.8% | |
TAKEDA PHARMACEUTICAL CO LTD | -3.7% | |
SANOFI-AVENTIS | -3.7% | |
GENMAB A/S | -3.4% | |
GILEAD SCIENCES INC | -3.3% | |
ROCHE HOLDING LTD | -3.3% | |
MERCK & CO. INC. | -3.2% | |
REGENERON PHARMACEUTICALS | -3.1% |